A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer ...

Drug resistance in difficult-to-treat rheumatoid arthritis can limit treatment response. Learn about methotrexate resistance, ...

Total expenditure stands at 1.5 billion: rethinking the way infections are diagnosed and treated, moving beyond a focus on ...

Prof. Andrew G. Myers to speak at the “Noble Talks” series in Jena Kerstin Breuer Pressestelle Leibniz-Institut für Nat ...

Ewha Womans University researchers who identified a new mechanism by which an enzyme causes antibiotic resistance. From left: Professor Cha Seon-sin, Professor Choi Seon, Dr. Bae Da-un, and Dr. Yoon ...

In recent years, in the world of home gardening and organic farming, as part of 'microbial farming,' there is a growing movement to create vegetables without relying on pesticides or fertilizers by ...

Bulgaria is facing a serious antimicrobial resistance crisis. Resistance to carbapenems among Klebsiella pneumoniae, one of the leading causes of hospital-acquired infections, reached 69% in 2025, the ...

David Felstead has spent the past six years being treated for a superbug infection in his left leg. After antibiotics stopped working, his health declined and he was at risk of losing his limb.

The CDC 2026 Antimicrobial Resistance Threats Report details an estimated 9.7 million annual infections and 50,800 deaths in the US.

Biossil assumes all future development and commercialization costs; Theriva is eligible for low-single-digit royalties on net sales, capped at $250 million.

Adagrasib (Krazati; MRTX849) is an oral, selective, irreversible KRAS G12C inhibitor that targets cancers harboring the KRAS p.G12C mutation. It binds covalently to the mutant KRAS protein, ...